Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.74
Price to sales ratio
5.92

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3243
VNDA
Vanda Pharmaceuticals Inc. - Common Stock
5.44 USD+1.68%+0.37%+6.04%-1.63%328.92 M USD
3267
IRD
Opus Genetics, Inc. - Common Stock
3.85 USD+1.32%-7.45%+11.59%+3.49%320.30 M USD
3315
FATE
Fate Therapeutics, Inc. - Common Stock
2.54 USD-1.17%+3.25%+9.01%+135.19%304.34 M USD
3321
RNAC
Cartesian Therapeutics, Inc. - Common Stock
9.97 USD-2.16%-3.67%+29.82%+8.84%301.65 M USD

Frequently asked questions about Orchestra BioMed Holdings, Inc. Ordinary Shares

What is the Orchestra BioMed Holdings, Inc. Ordinary Shares stock price today?

The current price of Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) is 5.11. Over the past 24 hours, the stock has changed by -2.85%. Follow the OBIO chart for real-time price dynamics.

What is the stock ticker of Orchestra BioMed Holdings, Inc. Ordinary Shares?

Orchestra BioMed Holdings, Inc. Ordinary Shares trades under the ticker OBIO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Orchestra BioMed Holdings, Inc. Ordinary Shares stock going up?

OBIO has changed by -6.58% over the last week, +32.73% over the last month, and +87.87% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Orchestra BioMed Holdings, Inc. Ordinary Shares?

Orchestra BioMed Holdings, Inc. Ordinary Shares currently has a market capitalization of 307.14 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Orchestra BioMed Holdings, Inc. Ordinary Shares earnings last quarter?

Last quarter, Orchestra BioMed Holdings, Inc. Ordinary Shares reported earnings of -0.38 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Orchestra BioMed Holdings, Inc. Ordinary Shares revenue for the last quarter?

Orchestra BioMed Holdings, Inc. Ordinary Shares reported quarterly revenue of 88 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Orchestra BioMed Holdings, Inc. Ordinary Shares net income for the last quarter?

Orchestra BioMed Holdings, Inc. Ordinary Shares reported net income of -23.75 M for the last quarter. The previous quarter showed -20.69 M, which means net income changed by -14.81%.

How many employees does Orchestra BioMed Holdings, Inc. Ordinary Shares have?

As of the latest available data, Orchestra BioMed Holdings, Inc. Ordinary Shares has 86 employees. Workforce size can provide additional context about the company's scale and operations.

What is Orchestra BioMed Holdings, Inc. Ordinary Shares EBITDA?

Orchestra BioMed Holdings, Inc. Ordinary Shares EBITDA is -22.26 M, and its EBITDA margin is -25.3 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Orchestra BioMed Holdings, Inc. Ordinary Shares stock?

You can buy Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Orchestra BioMed Holdings, Inc. Ordinary Shares stock?

Investing in Orchestra BioMed Holdings, Inc. Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the OBIO chart and related analysis on metatrader.com as part of your research.

News